• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to investors navigation
Insmed

Insmed

Powered by Purpose

LinkedIn Twitter Contact Us Job Opportunities

  • Culture
    • Our Culture
      • Mission & Vision
      • Careers
      • Responsibility
        • Inclusion at Insmed
        • Grants & Funding
        • Global Healthcare Compliance

    Our Global Company

    Find available career opportunities in the U.S., Japan, or Europe.

    Find Jobs

  • Patients
    • Our Patients
      • Disease Areas
        • NTM Lung Disease
        • Bronchiectasis
        • Pulmonary Arterial Hypertension
      • Resources
      • Patient Access

    Current Clinical Trials

    You may be eligible for one of our clinical trials.

    See if you may qualify

  • Science
    • Our Science
      • ARIKAYCE®
      • Our Programs
      • Pipeline
      • Clinical Trials
      • Our Research Team
      • Investigator-Initiated Research

    Our Research Team

    Working together to develop new medicines and technologies that have the potential to transform patients’ lives.

    Learn More

  • About
    • About Insmed
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs
Home / Investors/ News Releases

News Releases

Month Year
Su Mo Tu We Th Fr Sa
Month Year
Su Mo Tu We Th Fr Sa
Email Alerts
Advanced Search
  
Asset Types
           
 Basic Search
  • Jul 10, 2008
    Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
  • Jul 9, 2008
    Insmed to Present at Collins Stewart Fourth Annual Growth Conference
  • Jun 20, 2008
    Insmed to Request Hearing Before NASDAQ Panel to Review NASDAQ Staff Determination
  • May 8, 2008
    Insmed Announces First Quarter 2008 Financial Results
  • May 8, 2008
    /C O R R E C T I O N -- Insmed Inc./
  • Apr 29, 2008
    Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
  • Apr 24, 2008
    Insmed to Host First Quarter 2008 Conference Call
  • Apr 22, 2008
    Insmed to Present at CBI Follow-On Biologics Conference
  • Apr 16, 2008
    Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
  • Apr 10, 2008
    Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
  • Mar 8, 2008
    Insmed Announces Additional Information in Compliance With NASDAQ Rules
  • Mar 4, 2008
    Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
  • Feb 28, 2008
    Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
  • Feb 19, 2008
    Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
  • Feb 11, 2008
    Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
  • Feb 5, 2008
    Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
  • Feb 5, 2008
    Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
  • Jan 28, 2008
    Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
  • Jan 22, 2008
    Insmed Completes External Assessment of Myotonic Muscular Dystrophy Market
  • Dec 18, 2007
    Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
  • Dec 12, 2007
    Insmed Awarded $2.1 Million by Muscular Dystrophy Association
  • Dec 6, 2007
    Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
  • Dec 6, 2007
    Insmed Appoints Dennis M. Lanfear to Board Of Directors
  • Dec 3, 2007
    Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate Communications
  • Nov 13, 2007
    Insmed Advances Follow on Biologics Initiative
Show 5102550100 per page
  • «
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 25
  • »
Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

Sign Up

View the latest Insmed Investor Presentation

Download

Primary Sidebar

Investor Menu

  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

Investor Menu

Footer

Insmed
LinkedIn Twitter

Contact Us

Job Opportunities

  • Our Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Our Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Our Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
  • Events & Presentations
  • Stock Information
  • News Releases
  • SEC Filings
  • Annual Reports
  • Analyst Coverage
  • Corporate Governance
  • Email Alerts
  • Investor FAQs

© 2022 Insmed Incorporated. All Rights Reserved. Terms of Use Privacy Policy

Culture
Patients
Science
logo
  • Culture
    • Mission & Vision
    • Careers
    • Responsibility
      • Inclusion at Insmed
      • Grants & Funding
      • Global Healthcare Compliance
  • Patients
    • Disease Areas
      • NTM Lung Disease
      • Bronchiectasis
      • Pulmonary Arterial Hypertension
    • Resources
    • Patient Access
  • Science
    • ARIKAYCE®
    • Our Programs
    • Pipeline
    • Clinical Trials
    • Our Research Team
    • Investigator-Initiated Research
  • About
    • Management Team
    • Board of Directors
    • Partnerships
  • Investors
    • Investors
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Annual Reports
    • Analyst Coverage
    • Corporate Governance
    • Email Alerts
    • Investor FAQs

LinkedIn Twitter

Contact Us Job Opportunities

© 2022 Insmed Incorporated.
All Rights Reserved.

Terms of Use Privacy Policy